Stockholm Stock Exchange | Mid Cap
Oncopeptides
-96.07%
Latest
-
3 months
SEB EquitiesDNB MarketsCarnegieDNBABG Sundal Collier

Price Targets

Latest price targets per analyst.

AnalystPrice TargetDateUpside
SEB Equities0.35 SEKOct -21
-96.07%
DNB Markets5 SEKOct -21
Carnegie5.7 SEKOct -21
DNB250 SEKAug -21
ABG Sundal Collier64 SEKJul -21

About The Company

Oncopeptides AB is a Swedish pharmaceutical company that develops drugs for the treatment of cancer. It was founded in 2000, based on cancer research and supported by Healthcap, Industrifonden and Karolinska Institutet. Oncopeptode's shares have been listed on the Stockholm Stock Exchange's main list since 2017.
Wikipedia